Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2011, Article ID 875125, 7 pages
http://dx.doi.org/10.4061/2011/875125
Review Article

Role of Estrogen in Thyroid Function and Growth Regulation

1Postgraduation Program in Medicine and Medical Sciences, Federal University of Rio Grande do Sul, 90035-003 Porto Alegre, RS, Brazil
2Divisão de Medicina Interna, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcellos 2350/700, 90035-903 Porto Alegre, RS, Brazil

Received 14 January 2011; Accepted 24 February 2011

Academic Editor: Guillermo Juvenal

Copyright © 2011 Ana Paula Santin and Tania Weber Furlanetto. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. J. Vanderpump, W. M. G. Tunbridge, J. M. French et al., “The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Google Scholar · View at Scopus
  2. P. Laurberg, K. M. Pedersen, A. Hreidarsson, N. Sigfusson, E. Iversen, and P. R. Knudsen, “Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in iceland and in Jutland, Denmark,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 3, pp. 765–769, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Enewold, K. Zhu, E. Ron et al., “Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 3, pp. 784–791, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Z. Ben-Rafael, J. F. Struass, B. Arendash-Durand, L. Mastroianni, and G. L. Flickinger, “Changes in thyroid function tests and sex hormone binding globulin associated with treatment by gonadotropin,” Fertility and Sterility, vol. 48, no. 2, pp. 318–320, 1987. View at Google Scholar · View at Scopus
  5. B. M. Arafah, “Increased need for thyroxine in women with hypothyroidism during estrogen therapy,” New England Journal of Medicine, vol. 344, no. 23, pp. 1743–1749, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. Manole, B. Schildknecht, B. Gosnell, E. Adams, and M. Derwahl, “Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 1072–1077, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Heldring, A. Pike, S. Andersson et al., “Estrogen receptors: how do they signal and what are their targets,” Physiological Reviews, vol. 87, no. 3, pp. 905–931, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. C. M. Revankar, D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz, “A transmembrane intracellular estrogen receptor mediates rapid cell signaling,” Science, vol. 307, no. 5715, pp. 1625–1630, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. M. Gown, “Current issues in ER and HER2 testing by IHC in breast cancer,” Modern Pathology, vol. 21, no. 2, pp. S8–S15, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. M. Tavangar, M. Monajemzadeh, B. Larijani, and V. Haghpanah, “Immunohistochemical study of oestrogen receptors in 351 human thyroid glands,” Singapore Medical Journal, vol. 48, no. 8, pp. 744–747, 2007. View at Google Scholar
  11. S. A. Arain, M. H. Shah, S. A. Meo, and Q. Jamal, “Estrogen receptors in human thyroid gland. An immunohistochemical study,” Saudi Medical Journal, vol. 24, no. 2, pp. 174–178, 2003. View at Google Scholar
  12. I. Lewy-Trenda, “Estrogen receptors in the malignant and benign neoplasms of the thyroid,” Polski Merkuriusz Lekarski, vol. 5, no. 26, pp. 80–83, 1998. View at Google Scholar
  13. L. D. Valle, A. Ramina, S. Vianello, A. Fassina, P. Belvedere, and L. Colombo, “Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 10, pp. 3702–3709, 1998. View at Publisher · View at Google Scholar
  14. R. Bonacci, A. Pinchera, P. Fierabracci, A. Gigliotti, L. Grasso, and C. Giani, “Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue,” Journal of Endocrinological Investigation, vol. 19, no. 3, pp. 159–164, 1996. View at Google Scholar
  15. B. R. Jaklic, J. Rushin, and B. C. Ghosh, “Estrogen and progesterone receptors in thyroid lesions,” Annals of Surgical Oncology, vol. 2, no. 5, pp. 429–434, 1995. View at Publisher · View at Google Scholar
  16. A. Colomer, J. V. Martínez-Mas, X. Matias-Guiu et al., “Sex-steroid hormone receptors in human medullary thyroid carcinoma,” Modern Pathology, vol. 9, no. 1, pp. 68–72, 1996. View at Google Scholar
  17. H. Inoue, K. Oshimo, H. Miki et al., “Immunohistochemical study of estrogen receptor and estradiol on papillary thyroid carcinoma in young patients,” Journal of Surgical Oncology, vol. 53, no. 4, pp. 226–230, 1993. View at Google Scholar
  18. H. Inoue, K. Oshimo, H. Miki, M. Kawano, and Y. Monden, “Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma,” Cancer, vol. 72, no. 4, pp. 1364–1368, 1993. View at Google Scholar
  19. K. Yane, Y. Kitahori, N. Konishi et al., “Expression of the estrogen receptor in human thyroid neoplasms,” Cancer Letters, vol. 84, no. 1, pp. 59–66, 1994. View at Publisher · View at Google Scholar
  20. K. Yane, O. Tanaka, H. Miyahara, T. Matsunaga, Y. Kitahori, and Y. Hiasa, “Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors,” Journal of Otolaryngology of Japan, vol. 96, no. 5, pp. 787–790, 1993. View at Google Scholar
  21. Y. Hiasa, H. Nishioka, Y. Kitahori et al., “Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue,” Oncology, vol. 50, no. 2, pp. 132–136, 1993. View at Google Scholar
  22. N. M. Diaz, G. Mazoujian, and M. R. Wick, “Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma,” Archives of Pathology and Laboratory Medicine, vol. 115, no. 12, pp. 1203–1207, 1991. View at Google Scholar
  23. Y. Mizukami, T. Michigishi, A. Nonomura, T. Hashimoto, M. Noguchi, and F. Matsubara, “Estrogen and estrogen receptors in thyroid carcinomas,” Journal of Surgical Oncology, vol. 47, no. 3, pp. 165–169, 1991. View at Google Scholar
  24. N. Takeichi, H. Ito, R. Haruta, T. Matsuyama, K. Dohi, and E. Tahara, “Relation between estrogen receptor and malignancy of thyroid cancer,” Japanese Journal of Cancer Research, vol. 82, no. 1, pp. 19–22, 1991. View at Google Scholar
  25. G. S. Hong, I. T. Y. Sng, and K. C. Soo, “Oestrogen receptors in well differentiated thyroid cancers,” Annals of the Academy of Medicine Singapore, vol. 20, no. 6, pp. 767–769, 1991. View at Google Scholar
  26. H. Miki, K. Oshimo, H. Inoue, T. Morimoto, and Y. Monden, “Sex hormone receptors in human thyroid tissues,” Cancer, vol. 66, no. 8, pp. 1759–1762, 1990. View at Google Scholar
  27. R. Haruta, H. Ito, N. Takeichi, T. Matsuyama, K. Dohi, and E. Tahara, “An immunohistochemical study of estrogen receptors in thyroid carcinoma,” Gan No Rinsho, vol. 36, no. 4, pp. 465–468, 1990. View at Google Scholar
  28. P. K. Chaudhuri and R. Prinz, “Estrogen receptor in normal and neoplastic human thryoid tissue,” American Journal of Otolaryngology, vol. 10, no. 5, pp. 322–326, 1989. View at Google Scholar
  29. S. R. Money, W. Muss, W. L. Thelmo et al., “Immunocytochemical localization of estrogen and progesterone receptors in human thyroid,” Surgery, vol. 106, no. 6, pp. 975–979, 1989. View at Google Scholar
  30. O. H. Clark, P. L. Gerend, and M. Davis, “Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid disease,” Journal of Surgical Research, vol. 38, no. 2, pp. 89–96, 1985. View at Google Scholar
  31. M. Vaiman, Y. Olevson, L. Habler, A. Kessler, S. Zehavi, and J. Sandbank, “Diagnostic value of estrogen receptors in thyroid lesions,” Medical Science Monitor, vol. 16, no. 7, pp. 203–207, 2010. View at Google Scholar
  32. A. Winters, P. Friedlander, B. M. Jaffe, M. A. Khalek, K. Moroz, and E. Kandil, “A postmenopausal woman with gross cystic disease fluid protein-15 and estrogen receptor-positive recurrence of papillary thyroid cancer,” Thyroid, vol. 20, no. 12, pp. 1413–1417, 2010. View at Publisher · View at Google Scholar · View at PubMed
  33. G. Vannucchi, M. Perrino, S. Rossi et al., “Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy,” European Journal of Endocrinology, vol. 162, no. 1, pp. 145–151, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. M. A. Cho, M. K. Lee, K. H. Nam et al., “Expression and role of estrogen receptor α and β in medullary thyroid carcinoma: different roles in cancer growth and apoptosis,” Journal of Endocrinology, vol. 195, no. 2, pp. 255–263, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. C. Bléchet, P. Lecomte, L. De Calan, P. Beutter, and S. Guyétant, “Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma,” Virchows Archiv, vol. 450, no. 4, pp. 433–439, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. G. Ceresini, S. Morganti, V. Graiani et al., “Estrogen receptor (ER)-β, but not ER-α, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma,” Thyroid, vol. 16, no. 12, pp. 1215–1220, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. A. Molteni, R. L. Warpeha, L. Brizio-Molteni, and E. M. Fors, “Estradiol receptor-binding protein in head and neck neoplastic and normal tissue,” Archives of Surgery, vol. 116, no. 2, pp. 207–210, 1981. View at Google Scholar
  38. E. V. Jensen and E. R. DeSombre, “Estrogen receptor interaction,” Science, vol. 182, no. 4108, pp. 126–134, 1973. View at Google Scholar
  39. S. Mosselman, J. Polman, and R. Dijkema, “ERβ: identification and characterization of a novel human estrogen receptor,” FEBS Letters, vol. 392, no. 1, pp. 49–53, 1996. View at Publisher · View at Google Scholar
  40. G. G. Chen, A. C. Vlantis, Q. Zeng, and C. A. Van Hasselt, “Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer,” Current Cancer Drug Targets, vol. 8, no. 5, pp. 367–377, 2008. View at Publisher · View at Google Scholar
  41. A. M. Sotoca, H. Van den Berg, J. Vervoort et al., “Influence of cellular ERα/ERβ ratio on the ERα-agonist induced proliferation of human T47D breast cancer cells,” Toxicological Sciences, vol. 105, no. 2, pp. 303–311, 2008. View at Publisher · View at Google Scholar · View at PubMed
  42. A. Kumar, C. M. Klinge, and R. E. Goldstein, “Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors α and β,” International Journal of Oncology, vol. 36, no. 5, pp. 1067–1080, 2010. View at Publisher · View at Google Scholar
  43. S. Rajoria, R. Suriano, A. Shanmugam et al., “Metastatic phenotype is regulated by estrogen in thyroid cells,” Thyroid, vol. 20, no. 1, pp. 33–41, 2010. View at Publisher · View at Google Scholar · View at PubMed
  44. Q. Zeng, G. G. Chen, A. C. Vlantis, G. M. Tse, and C. A. Van Hasselt, “The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas,” Journal of Pathology, vol. 214, no. 4, pp. 425–433, 2008. View at Publisher · View at Google Scholar · View at PubMed
  45. Q. Zeng, G. G. Chen, A. C. Vlantis, and C. A. Van Hasselt, “Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway,” Cell Proliferation, vol. 40, no. 6, pp. 921–935, 2007. View at Publisher · View at Google Scholar · View at PubMed
  46. A. Vivacqua, D. Bonofiglio, L. Albanito et al., “17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30,” Molecular Pharmacology, vol. 70, no. 4, pp. 1414–1423, 2006. View at Publisher · View at Google Scholar · View at PubMed
  47. M. L. Lee, G. G. Chen, A. C. Vlantis, G. M. K. Tse, B. C. H. Leung, and C. A. Van Hasselt, “Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL,” Cancer Journal, vol. 11, no. 2, pp. 113–121, 2005. View at Publisher · View at Google Scholar
  48. K. S. Banu, P. Govindarajulu, and M. M. Aruldhas, “Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action,” Endocrine Pathology, vol. 12, no. 3, pp. 315–327, 2001. View at Publisher · View at Google Scholar
  49. T. W. Furlanetto, R. B. Nunes, A. M. I. Sopelsa, and R. M. B. Maciel, “Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells,” Brazilian Journal of Medical and Biological Research, vol. 34, no. 2, pp. 259–263, 2001. View at Google Scholar
  50. T. W. Furlanetto, L. Q. Nguyen, and J. L. Jameson, “Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells,” Endocrinology, vol. 140, no. 12, pp. 5705–5711, 1999. View at Google Scholar
  51. N. Nagy, I. Camby, C. Decaestecker et al., “The influence of L-triiodothyronine, L-thyroxine, estradiol-17β, the luteinizing-hormone-releasing hormone, the epidermal growth factor and gastrin on cell proliferation in organ cultures of 35 benign and 13 malignant human thyroid tumors,” Journal of Cancer Research and Clinical Oncology, vol. 125, no. 6, pp. 361–368, 1999. View at Publisher · View at Google Scholar
  52. L. Del Senno, E. Degli Uberti, S. Hanau, R. Piva, R. Rossi, and G. Trasforini, “In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids,” Molecular and Cellular Endocrinology, vol. 63, no. 1-2, pp. 67–74, 1989. View at Google Scholar
  53. K. Yang, C. E. Pearson, and N. A. Samaan, “Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture,” Cancer Research, vol. 48, no. 10, pp. 2760–2763, 1988. View at Google Scholar
  54. D. O. Kavanagh, M. McIlroy, E. Myers et al., “The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2,” Endocrine-Related Cancer, vol. 17, no. 1, pp. 255–264, 2010. View at Publisher · View at Google Scholar · View at PubMed
  55. C. Lee et al., “Estrogen receptors and glucocorticoid receptors in human well-differentiated thyroid cancer,” International Journal of Molecular Medicine, vol. 2, no. 2, pp. 229–233, 1998. View at Google Scholar
  56. C. Egawa, Y. Miyoshi, K. Iwao, E. Shiba, and S. Noguchi, “Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction,” Oncology, vol. 61, no. 4, pp. 293–298, 2001. View at Publisher · View at Google Scholar
  57. T. Hoelting, S. Tezelman, A. E. Siperstein, Q. Y. Duh, and O. H. Clark, “Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro,” Thyroid, vol. 5, no. 1, pp. 35–40, 1995. View at Google Scholar
  58. V. Marsaud, A. Gougelet, S. Maillard, and J.-M. Renoir, “Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells,” Molecular Endocrinology, vol. 17, no. 10, pp. 2013–2027, 2003. View at Publisher · View at Google Scholar · View at PubMed
  59. M. Saji and M. D. Ringel, “The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors,” Molecular and Cellular Endocrinology, vol. 321, no. 1, pp. 20–28, 2010. View at Publisher · View at Google Scholar · View at PubMed
  60. L. Altucci, R. Addeo, L. Cicatiello et al., “17β-estradiol induces cyclin D gene transcription, p36(D)-p34(cdk4) complex activation and p105(Rb) phosphorylation during mitogenic stimulation of G-arrested human breast cancer cells,” Oncogene, vol. 12, no. 11, pp. 2315–2324, 1996. View at Google Scholar
  61. S. Sporny, D. Slowinska-Klencka, and M. Ratynska, “Cyclin D1 expression in primary thyroid carcinomas,” Neuroendocrinology Letters, vol. 26, no. 6, pp. 815–818, 2005. View at Google Scholar
  62. Y. Shi, M. Zou, E. Varkondi, A. Nagy, L. Kozma, and N. R. Farid, “Cyclin D1 in thyroid carcinomas,” Thyroid, vol. 11, no. 7, pp. 709–710, 2001. View at Google Scholar
  63. F. Basolo, M. A. Caligo, A. Pinchera et al., “Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and ki67 labeling index,” Thyroid, vol. 10, no. 9, pp. 741–746, 2000. View at Google Scholar
  64. D. Lazzereschi, L. Sambuco, C. Carnuvale Scalzo et al., “Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas,” International Journal of Cancer, vol. 76, no. 6, pp. 806–811, 1998. View at Publisher · View at Google Scholar
  65. S. Wang, R. V. Lloyd, M. J. Hutzler, M. S. Safran, N. A. Patwardhan, and A. Khan, “The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer,” Modern Pathology, vol. 13, no. 8, pp. 882–887, 2000. View at Google Scholar
  66. M. L. C. Khoo, S. Ezzat, J. L. Freeman, and S. L. Asa, “Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1810–1813, 2002. View at Publisher · View at Google Scholar